Forbes -
1 Dec 2020 15:00

We believe that Bristol Myers Squibb stock is a good buying opportunity at the present time. BMY stock trades near $63 currently and it is, in fact, down 6% from its pre-Covid high of $67 in February 2020 - just before the coronavirus pandemic hit the world. BMY stock has rallied over 35% since...
Share this Article
Comment on this Article
Please to comment